PI3K通路与乳腺癌的关系及其意义的研究进展
被引量:2
摘要
磷酸肌醇3-激酶(PI3K)通路与乳腺癌病理生理之间的密切关系已逐渐被阐明,PI3K有望成为靶向治疗的新型靶点。笔者就近年PI3K通路的活性异常与乳腺癌细胞发生发展、转移、耐药的关系以及其作为治疗靶点的应用价值的研究进展作一综述。
出处
《中国普通外科杂志》
CAS
CSCD
北大核心
2011年第11期1240-1243,共4页
China Journal of General Surgery
参考文献32
-
1O'Reilly KE, Rojo F, She QB, et al. mTOR inhibition in- duces upstream receptor tyrosine kinase signaling and activates Akt[J~. Cancer Res, 2006, 66(3) :1500- 1508.
-
2Xu Z, Stokoe D, Kane LP, et al. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells[ J]. Cell Growth Differ, 2002, 13 (7) : 285 -296.
-
3Bachman KE, Argani P, Samuels Y, et al. The PIK3 CA gene is mutated with high frequency in human breast cancers [ J ]. Cancer Biol Ther, 2004, 3 (8) :772 - 775.
-
4Hennessy BT, Smith DL, Ram PT, et al. Exploiting the PI3 K/AKT pathway for cancer drug discovery [ J ] . Nat Rev Drug Discov, 2005 , 4(12) :988 - 1004.
-
5Carpten JD, Faber AL, Horn C, et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer [J]. Nature, 2007, 448(7152) :439 -444.
-
6Stcmke-Hale K, Gonzalez-Angulo AM, Lluch A, et al. An integrative genomic and proteomic analysis of PIK3 CA, PTEN, and AKT mutations in breast cancer [ J ]. Cancer Res, 2008, 68(15):6084-6091.
-
7Kalinsky K, Jacks LM, Heguy A, et al. PlK3 CA mutation associates with improved outcome in breast cancer [ J ]. Clin Cancer Res, 2009, 15(16) :5049 -5059.
-
8Keely PJ, Westwick JK, Whitehead IP, et al. Cdc42 and Rac 1 induce integrin-mediated cell motility and invasiveness through PI(3)K[JI. Nature, 1997, 390(6660) :632 -636.
-
9Pang H, Flinn R, Patsialou A, et al. Differential enhance- ment of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase [ J ]. Cancer Res, 2009, 69 (23) : 8868 - 8876.
-
10Gonzalez - Angulo AM, Ferrer- Lozano J, Stemke - Hale K, et al. PI3 K pathway mutations and P'I~N levels in primary and metastatic breast cancer[ J ]. Mol Cancer Ther, 2011 , 10 (6) :1093 - 1101.
同被引文献40
-
1Yang Z, Klionsky DJ. Eaten alive: a history of macroantophagy[J]. Nat Cell Biol, 2010, 12(9):814-822.
-
2Aita VM, Liang XH, Murty VV, et al. Cloning and genomic organization of Beclinl, a candidate tumor suppressor gene on chromosome 17q21[J]. Genomics, 1999, 59(1):59-65.
-
3Li Z, Chen B, Wu Y, et al. Genetic and epigenetic silencing of the Beclinl gene in sporadic breast tumors[J]. BMC Cancers 2010, 10:98.
-
4Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclinl-dependent autophagy [J]. Cell, 2005, 122(6):927- 939.
-
5Tooze SA, Yoshimori T. The origin of the autophagosomal membrane [J]. Nat Cell Biol, 2010, 12(9):831-835.
-
6Kung CP, Budina A, Balaburski G, et al. Autophagy in tumor suppression and cancer therapy [J]. Crit Rev Eukaryot Gene Expr, 2011, 21(1):71-100.
-
7Morselli E, Galluzzi L, Kepp O, et al. Anti- and pro-tumor functions of autophagy[J]. Biochim Biophys Acta, 2009, 1793(9): 1524-1532.
-
8Brech A, Ahlquist T, Lothe RA, et al. Autophagy in tumor suppression and promotion [J]. Mol Oncol, 2009, 3(4):366-375.
-
9Jin S. p53, Autophagy and tumor suppression[J]. Autophagy, 2005, 1(3):171-173.
-
10Degenhardt K, Mathew R, Beaudoin B, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis[J]. Cancer Cell, 2006, 10(1):51-64.
引证文献2
-
1王日玮,吴爱国.自噬基因Beclin1与乳腺癌的关系[J].中国普通外科杂志,2012,21(5):591-596. 被引量:9
-
2焦明文,袁凯,王玉龙,陈鸿强,周婷,付荣湛.MK-2206逆转人乳腺癌细胞耐药的作用及机制研究[J].中国普通外科杂志,2014,23(11):1494-1500. 被引量:1
二级引证文献10
-
1陈键,刘田雨,俞伟,肖依楠,杨雨佳,蒋碧梅,涂自智,肖献忠.甘草素对人乳腺癌MCF-7细胞增殖、凋亡及自噬的影响[J].中国普通外科杂志,2013,22(11):1466-1470. 被引量:12
-
2徐志红,张悦民,郁佳敏,高蓓莉,胡家安.细胞自噬在吉非替尼治疗非小细胞肺癌中的作用及其机制研究[J].现代生物医学进展,2014,14(5):822-825. 被引量:3
-
3张海洋,厉冰,杨玉兵,宋展,王耿泽.大肠癌中抑制基因BCL-2、p53与Beclin-1的表达及其与肠癌生物学行为的关系[J].中国普通外科杂志,2014,23(10):1429-1433. 被引量:3
-
4邵明涛,潘运龙,覃莉,丁晖,赵晓旭,吴晓波.纳米金增加阿霉素耐药肝癌细胞株敏感性的实验研究[J].中国普通外科杂志,2015,24(1):52-56.
-
5刘畅,张涛,马媛萍,方健松,陈远能.Beclin1诱导自噬在胃癌发生发展过程的机制研究[J].辽宁中医杂志,2016,43(4):888-889. 被引量:4
-
6刘汀,李小曼,白宁,关奕.细胞自噬在乳腺癌中研究进展[J].解剖科学进展,2016,22(3):344-346. 被引量:1
-
7潘贇昊,顾岩,石阳,汪成.Beclin1表达水平与乳腺癌临床分期相关性的研究[J].临床检验杂志(电子版),2017,6(3):445-447. 被引量:5
-
8冯少博,吴爱国,王梦川,纪术峰,邵国利,张健,陈丹珣,雷姗姗,赵侃侃,王子祥.Beclin 1基因过表达对人乳腺癌细胞BT-549裸鼠皮下成瘤生长影响研究[J].中华肿瘤防治杂志,2017,24(21):1495-1500. 被引量:4
-
9邹华伟,陈澎涛,刘洋.自噬相关基因Beclin1与乳腺癌病理相关性分析[J].实用癌症杂志,2021,36(6):895-898.
-
10张娜娜.Caspase-3和Bcl-2表达与乳腺癌细胞凋亡及其临床病理特征的相关性分析[J].实用癌症杂志,2021,36(10):1609-1613. 被引量:7
-
1程鹏,高志强,胡宜,刘云会.骨髓间充质干细胞向胶质瘤迁移机制的实验研究[J].中华神经外科疾病研究杂志,2013,12(3):214-217.
-
2郭绍卫,王亚轩,常学良,李景东,韩振伟,滕志海,黎玮.Rab25与PI3K在肾透明细胞癌中的表达及临床意义[J].临床误诊误治,2016,29(6):49-52. 被引量:1
-
3李宇清,杨惠玲.p-Akt和P27的生物学特性及其与鼻咽癌关系的研究进展[J].国际内科学杂志,2009,36(6):327-330. 被引量:2
-
4陈炆颖,蔡少鑫,洪如钧,林明,陈愉生.Six1通过PI3K通路抑制肺癌细胞A549的增殖和迁移[J].福建医药杂志,2014,36(5):56-59. 被引量:2
-
5刘洁,于皆平,罗和生,于红刚.Mcl-1、PI3K通路活化对胃癌细胞生长及化疗敏感性的影响[J].武汉大学学报(医学版),2009,30(4):450-454.
-
6曾峰,谭永嘉,曾庆良,程晓明,孔凡立,孙素红.CEF新辅助化疗对乳腺癌MAPK/PI3K通路的影响[J].贵州医药,2012,36(8):683-685.
-
7徐邱鸿,逯庆玲,陈洪宇,王明芳,马秀岩,娄秀辉,于欣,宋立新,王乾,王立.骨桥蛋白促进SKOV3卵巢癌细胞增殖、迁移及侵袭能力[J].中国现代医生,2014,52(36):1-4. 被引量:2
-
8李鹏,张庆九,马法,刘岚,李旭蕊,李晓燕.PI3K、Akt和mTOR在无功能性垂体腺瘤中的表达[J].河北医科大学学报,2015,36(9):1064-1068. 被引量:3
-
9欧柳菁,张弛,段学宁,刘荫华.乳腺癌新辅助化疗疗效与PI3K/mTOR通路的相关性分析[J].中华医学杂志,2012,92(34):2382-2385. 被引量:9
-
10科学家确认卵巢癌一对重要的致癌基因和抑癌基因[J].肿瘤防治研究,2015,42(3):318-318.